Fatty acid synthase (FASN) activity may partly account for the link between ErbB2 and diabetes because the overexpression of ErbB2 through a phosphatidylinositol 3'-kinase-dependent pathway promotes the expression of FASN29. Here, FASN is linked to diabetes mellitus.